Skip to main content
SpringerLink
Log in
Book cover

23. Hämophilie-Symposion pp 35–40Cite as

Therapie neurologischer HIV-Komplikationen

  • Conference paper

  • 25 Accesses

Zusammenfassung

Bei der Therapie neurologischer Komplikationen der HIV-Infektion kann wie in der Diagnostik grundsätzlich unterschieden werden zwischen primären (d.h. direkt HIV-bedingten) und sekundären (d.h. indirekt HIV-induzierten) Neuromanifestationen

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322:1098–1105

    Article  PubMed  CAS  Google Scholar 

  2. Dix RD, Bredesen DE (1988) Opportunistic viral infections in acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE (eds) AIDS and the nervous system. Raven Press, New York, pp 221–261

    Google Scholar 

  3. Dreyer EB, Kaiser PK, Offermann JT, Lipton SA (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364–367

    Article  PubMed  CAS  Google Scholar 

  4. Enzensberger W (1989) Neuromanifestationen bei AIDS. Schwer Verlag, Stuttgart

    Google Scholar 

  5. Enzensberger W, Fischer P-A (1990) Einfluß der HIV-Therapie auf das Nervensystem. 3. Deutscher AIDS-Kongreß, Hamburg, Futuramed Verlagsgesellschaft München, pp 150

    Google Scholar 

  6. Enzensberger W (1991) Neuro-AIDS — Aktuelle Entwicklungen. Akt Neurol 18:42–48

    Article  Google Scholar 

  7. Fischi MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D, AZT Collaborative Working Group (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317:185–191

    Article  Google Scholar 

  8. Goebel F-D (1989) Probleme der Therapieforschung für HIV-Infektionen und AIDS. AIFO 4:577–579

    Google Scholar 

  9. Haverkos HW (1987) Assessment of therapy for toxoplasma encephalitis. The TE study group. Am J Med 82:907–914

    Article  PubMed  CAS  Google Scholar 

  10. Klinker H, Joeres R, Richter E (1991) Pyrimethamine-plasma-concentrations during prophylaxis of cerebral toxoplasmosis (CTX) in patients with advanced HIV-infection. VII. International Conference on AIDS, Florence, abstract MB 2014

    Google Scholar 

  11. McArthur JC, Miller EN, Seines OA, Becker JT, Cohen BA, Starkey D, Hoover D, Saah A (1990) Effects of Long-term Zidovudine Use on Neuropsychological Performance in the Multicenter AIDS Cohort Study. VI. International Conference on AIDS, San Francisco, abstract FB 31

    Google Scholar 

  12. Pohle HD, Eichenlaub D (1987) ZNS-Toxoplasmose bei AIDS-Patienten. AIFO 2:122–135

    Google Scholar 

  13. Pons VG, Jacobs RA, Hollander H (1988) Nonviral infections of the central nervous system in patients with acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE (eds) AIDS and the nervous system. Raven Press, New York, pp 263–283

    Google Scholar 

  14. Portegies P, de Gans J, Lange JMA, Derix MMA, Speelman H, Bakker M, Danner SA, Goudsmit J (1989) Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. Br Med J 299:819–821

    Article  CAS  Google Scholar 

  15. Richmann DD, Fischi MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Nusinoff-Lehrman S, AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 317:192–197

    Article  Google Scholar 

  16. Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL, and the AZT collaborative working group (1988) Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319:1573–1578

    Article  PubMed  CAS  Google Scholar 

  17. So YT, Choucair A, Davis RL, Wara WM, Ziegler JL, Sheline GE, Beckstead JH (1988) Neoplasms of the central nervous system in acquired immunodeficiency syndrome. In: Rosenblum ML, Levy RM, Bredesen DE (eds) AIDS and the nervous system. Raven Press, New York, pp 285–300

    Google Scholar 

  18. Staib F (1987) Kryptokokkose bei AIDS aus mykologisch-diagnostischer und-epidemiologischer Sicht. AIFO 2:363–382

    Google Scholar 

  19. Tartaglione T, Collier AC, Coombs RW, Opheim KE, Cummings DK, Mackay R, Benedetti J, Corey L (1990) Correlation between CSF zidovudine concentration and neurologic and CSF findings in AIDS patients receiving oral zidovudine therapy. VI. International Conference on AIDS, San Francisco, abstract FB 414

    Google Scholar 

  20. Yarchoan R, Pluda JM, Thomas RV, Mitsuya H, Brouwers P, Wyvill KM, Hartman N, Johns DG, Broder S (1990) Long-term toxicity/activity profile of 2′,3′-dideoxyinosine in AIDS or AIDS-related complex. Lancet II: 526–529

    Article  Google Scholar 

Download references

Authors
  1. W. Enzensberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Angiologie, Universitätsklinikum, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Inge Scharrer

  2. Hämostaseologische Abteilung, Med. Univ.-Klinik Innenstadt, Ziemssenstraße 1a, D-80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Enzensberger, W. (1993). Therapie neurologischer HIV-Komplikationen. In: Scharrer, I., Schramm, W. (eds) 23. Hämophilie-Symposion. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78359-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78359-3_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-56955-8

  • Online ISBN: 978-3-642-78359-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation